Please assess the completion status of the following clinical trial:

Trial Title: GIST and Memory and Attention Adaptation Training

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 and above;~2. Diagnosis of Gastrointestinal stromal tumor (GIST);~3. At least 1 year post-initiation of TKI therapy;~4. Report cognitive problems of memory and concentration attributed to GIST and/or treatment with a score of 10 or below on the FACT-Cog Impact on Quality of Life Scale;~5. Able to speak and read English;~6. Able to provide IRB-approved written informed consent; and~7. Willingness to use videoconferencing and complete phone-based neurocognitive assessments~Exclusion Criteria:~1. Previous treatment with a tyrosine kinase inhibitor medication for a non-GIST diagnosis~2. Previous CNS radiation, intrathecal therapy, or CNS-involved surgery;~3. Previous cancer history with the exception of non-melanoma skin cancer;~4. Previous exposure to chemotherapy with another cancer or due to other medical condition (e.g., methotrexate exposure for treatment of rheumatoid arthritis);~5. Scoring 3 or below on the 6-item cognitive screen designed to detect severe memory disorders;1~6. Significant neurodevelopmental, neurobehavioral, or medical risk factors likely to affect cognitive functioning (e.g., history of neurological disorder, stroke, traumatic brain injury greater than mild severity, such as loss of consciousness \>30 minutes, medical disorder that is unstable or likely to affect cognition such as metabolic disorder, heart attack, uncontrolled diabetes or endocrine dysfunction);~7. Current severe DSM-5 mental disorder criteria, including but not limited to neurodevelopmental, substance abuse, mood, anxiety, or psychotic disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Memory and Attention Adaptation Training (MAAT) (Type: EXPERIMENTAL): A cognitive-behavioral therapy (CBT) designed for the treatment of Cancer-Related Cognitive Impairment (CRCI)

Based on this trial design, predict the completion outcome and termination type (if applicable).